Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence
Background GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The f...
Saved in:
Published in | Allergy (Copenhagen) Vol. 71; no. 8; pp. 1210 - 1218 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Zurich
Blackwell Publishing Ltd
01.08.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard‐to‐treat conditions such as urticaria.
Aims
Here, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA²LEN UCAREs.
Results
The main aims of GA²LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA²LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit.
Discussion and Conclusion
The GA²LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally. |
---|---|
AbstractList | Background GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard-to-treat conditions such as urticaria. Aims Here, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA²LEN UCAREs. Results The main aims of GA²LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA²LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit. Discussion and Conclusion The GA²LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally. Background GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard‐to‐treat conditions such as urticaria. Aims Here, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA²LEN UCAREs. Results The main aims of GA²LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA²LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit. Discussion and Conclusion The GA²LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally. |
Author | Meshkova, R. Zuberbier, T. Saini, S. S. Magerl, M. Bousquet, J. Godse, K. V. Makris, M. Canonica, G. W. Church, M. K. Bindslev‐Jensen, C. Zhao, Z. Grattan, C. E. Kocatürk, E. Sussman, G. Toubi, E. Maurer, M. Hide, M. Gimenez‐Arnau, A. Metz, M. |
Author_xml | – sequence: 1 givenname: M. surname: Maurer fullname: Maurer, M. organization: Charité ‐ Universitätsmedizin Berlin – sequence: 2 givenname: M. surname: Metz fullname: Metz, M. organization: Charité ‐ Universitätsmedizin Berlin – sequence: 3 givenname: C. surname: Bindslev‐Jensen fullname: Bindslev‐Jensen, C. organization: Odense University Hospital – sequence: 4 givenname: J. surname: Bousquet fullname: Bousquet, J. organization: Université Versailles St‐Quentin‐en‐Yvelines – sequence: 5 givenname: G. W. surname: Canonica fullname: Canonica, G. W. organization: University of Genoa – sequence: 6 givenname: M. K. surname: Church fullname: Church, M. K. organization: Charité ‐ Universitätsmedizin Berlin – sequence: 7 givenname: K. V. surname: Godse fullname: Godse, K. V. organization: D.Y. Patil School of Medicine – sequence: 8 givenname: C. E. surname: Grattan fullname: Grattan, C. E. organization: Norfolk and Norwich University Hospital – sequence: 9 givenname: M. surname: Hide fullname: Hide, M. organization: Hiroshima University – sequence: 10 givenname: E. surname: Kocatürk fullname: Kocatürk, E. organization: Okmeydani Training and Research Hospital – sequence: 11 givenname: M. surname: Magerl fullname: Magerl, M. organization: Charité ‐ Universitätsmedizin Berlin – sequence: 12 givenname: M. surname: Makris fullname: Makris, M. organization: Attikon University Hospital – sequence: 13 givenname: R. surname: Meshkova fullname: Meshkova, R. organization: Smolensk State Medical University – sequence: 14 givenname: S. S. surname: Saini fullname: Saini, S. S. organization: Johns Hopkins University – sequence: 15 givenname: G. surname: Sussman fullname: Sussman, G. organization: University of Toronto – sequence: 16 givenname: E. surname: Toubi fullname: Toubi, E. organization: The Technion – sequence: 17 givenname: Z. surname: Zhao fullname: Zhao, Z. organization: Peking University, First Hospital – sequence: 18 givenname: T. surname: Zuberbier fullname: Zuberbier, T. organization: Charité ‐ Universitätsmedizin Berlin – sequence: 19 givenname: A. surname: Gimenez‐Arnau fullname: Gimenez‐Arnau, A. organization: Universitat Autònoma |
BookMark | eNotkE1LAzEQhoNUsK0e_AcLXt022ezm41hqrcKiIPYmhNhMICWbrdkt2n_fbOsc5oPnnRl4J2gU2gAI3RM8Iynm2vsZKSQmV2hMqBS5lLIaoTEmuMrLioobNOm6HcaYJ9UYfT2BdcH1rg2PmXZNl3IwmWv2HhoIvR5I1tpsvSjq1Vu2ib3b6uh0tkwUYjewD7AQIWzhvLv624L3w3iLrq32Hdz91ynaPK8-ly95_b5-XS7qfEeYJLnhwAgtiMGGMimNlJZqhjG1tpCcGmYJlN9WYqNZIcpCcya4YLJilaC8LOkUPVzu7mP7c4CuV7v2EEN6qYjABeWMV1VSzS-qX-fhqPbRNToeFcFqcE4l59TZObWo63NDT5SGYjo |
ContentType | Journal Article |
Copyright | 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Copyright © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
Copyright_xml | – notice: 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: Copyright © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
DBID | 7T5 H94 K9. |
DOI | 10.1111/all.12901 |
DatabaseName | Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) |
DatabaseTitle | AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1398-9995 |
EndPage | 1218 |
ExternalDocumentID | 4110950441 ALL12901 |
Genre | article |
GrantInformation_xml | – fundername: UCB – fundername: Takeda – fundername: Uriach – fundername: Genentech – fundername: Novartis – fundername: Almirall – fundername: MSD – fundername: Sanofi – fundername: UNEV – fundername: Moxie |
GroupedDBID | .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT 7T5 H94 K9. |
ID | FETCH-LOGICAL-j1691-d7e61321d0d3699d99f3a6003ff2973d6f1e4bf90da62842a7687869565837443 |
IEDL.DBID | DR2 |
ISSN | 0105-4538 |
IngestDate | Fri Sep 13 05:48:39 EDT 2024 Sat Aug 24 01:01:47 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-j1691-d7e61321d0d3699d99f3a6003ff2973d6f1e4bf90da62842a7687869565837443 |
OpenAccessLink | http://repositori.upf.edu/bitstream/10230/27113/1/maurer-all-defi.pdf |
PQID | 1802376755 |
PQPubID | 34098 |
PageCount | 9 |
ParticipantIDs | proquest_journals_1802376755 wiley_primary_10_1111_all_12901_ALL12901 |
PublicationCentury | 2000 |
PublicationDate | August 2016 |
PublicationDateYYYYMMDD | 2016-08-01 |
PublicationDate_xml | – month: 08 year: 2016 text: August 2016 |
PublicationDecade | 2010 |
PublicationPlace | Zurich |
PublicationPlace_xml | – name: Zurich |
PublicationTitle | Allergy (Copenhagen) |
PublicationYear | 2016 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2010; 65 2015; 5 2011; 128 2015; 29 2013; 68 2015; 135 2015; 40 2013; 368 2011; 66 2014; 69 2016; 71 2005; 60 2013; 132 2011; 4 2014; 133 2012; 67 2016; 174 2014; 75 2016; 172 |
References_xml | – volume: 65 start-page: 743 year: 2010 end-page: 752 article-title: Establishing a standardized quality management system for the European Health Network GA LEN publication-title: Allergy – volume: 68 start-page: 1185 year: 2013 end-page: 1192 article-title: Development, validation, and initial results of the Angioedema Activity Score publication-title: Allergy – volume: 75 start-page: 88 year: 2014 end-page: 93 article-title: Development of a standardized pulse‐controlled ergometry test for diagnosing and investigating cholinergic urticaria publication-title: J Dermatol Sci – volume: 29 start-page: 2043 year: 2015 end-page: 2045 article-title: An improved Peltier effect‐based instrument for critical temperature threshold measurement in cold‐ and heat‐induced urticaria publication-title: J Eur Acad Dermatol Venereol – volume: 66 start-page: 317 year: 2011 end-page: 330 article-title: Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report publication-title: Allergy – volume: 5 start-page: 29 year: 2015 article-title: ASSURE‐CSU: a real‐world study of burden of disease in patients with symptomatic chronic spontaneous urticaria publication-title: Clin Transl Allergy – volume: 71 start-page: 780 year: 2016 end-page: 802 article-title: The definition, diagnostic testing and management of chronic inducible urticarias – update and revision of the EAACI/GA²LEN/EDF/UNEV 2009 consensus panel recommendations publication-title: Allergy – volume: 368 start-page: 924 year: 2013 end-page: 935 article-title: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria publication-title: N Engl J Med – volume: 135 start-page: 925 year: 2015 article-title: Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo‐controlled study publication-title: J Invest Dermatol – volume: 69 start-page: 868 year: 2014 end-page: 887 article-title: The EAACI/GA LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update publication-title: Allergy – volume: 4 start-page: 45 year: 2011 end-page: 46 article-title: Effects of a novel GA?LEN training program on urticaria on the knowledge of general practitioners in Saudi‐Arabia publication-title: World Allergy Organ J – volume: 133 start-page: 1365 year: 2014 end-page: 1372 article-title: Development and validation of the Urticaria Control Test: a patient‐reported outcome instrument for assessing urticaria control publication-title: J Allergy Clin Immunol – volume: 67 start-page: 1289 year: 2012 end-page: 1298 article-title: Development and construct validation of the angioedema quality of life questionnaire publication-title: Allergy – volume: 132 start-page: 101 year: 2013 end-page: 109 article-title: Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy publication-title: J Allergy Clin Immunol – volume: 128 start-page: 202 year: 2011 end-page: 209 article-title: Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase publication-title: J Allergy Clin Immunol – volume: 71 start-page: 1203 year: 2016 end-page: 1209 article-title: The angioedema quality of life questionnaire (AE‐QoL) – assessment of sensitivity to change and minimal clinically important difference publication-title: Allergy – volume: 174 start-page: 892 year: 2016 end-page: 894 article-title: ATTENTUS, a German online survey of chronic urticaria patients highlighting the burden of disease, unmet needs and real‐life clinical practice publication-title: Br J Dermatol – volume: 172 start-page: 56 year: 2016 end-page: 63 article-title: Diagnosis and classification of mastocytosis in non‐specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients publication-title: Br J Haematol – volume: 40 start-page: 399 year: 2015 end-page: 403 article-title: Validation of a simplified provocation instrument for diagnosis and threshold testing of symptomatic dermographism publication-title: Clin Exp Dermatol – article-title: Omalizumab for the treatment of chronic spontaneous urticaria: a meta‐analysis of randomized clinical trials publication-title: J Allergy Clin Immunol – volume: 60 start-page: 1073 year: 2005 end-page: 1078 article-title: A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU‐QoL) publication-title: Allergy |
SSID | ssj0007290 |
Score | 2.2268183 |
Snippet | Background
GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of... Background GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of... |
SourceID | proquest wiley |
SourceType | Aggregation Database Publisher |
StartPage | 1210 |
SubjectTerms | Allergies angioedema center Disease management excellence management Skin urticaria |
Title | Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.12901 https://www.proquest.com/docview/1802376755/abstract/ |
Volume | 71 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA5jB_Hib3FzSg4ePJjRtUna4mno5pBtB3Gww6AkTQLTrRO3gfjX-5K2c3oSL6UlSQmvec33vbx8QehKxpSxtMWIlhEl1GhGZKwEkYJxwbUJPW2J4mDIeyP6OGbjCrot98Lk-hCbgJv1DPe_tg4u5HLLycVs1rRBFEt9rJCeBURP39JRYRFfAfxAKHh1oSpks3g2LX-gym1s6iaX7j6alN3Kc0pem-uVbKafvxQb_9nvA7RXgE7czkfJIaro7AjtDIpl9WM0uddmmrnkrRsspvMlXDOFp_MyudyW4IXBD22_3xnikX0RkGyBbXAYAKQt20jWuradD7ckAI8naNTtPN_1SHHsAnmxyjlEhRrmeL-lPBXwOFZxbAIBuCgwxh50pbhpaSpN7CnBYXLzBTCWMOJAtBiwXUqDU1TNFpk-QxiqhozJFDgho0JFIqReEJjU80WkuadrqFF-gKTwnWXiNOmsxgyroWtnyeQtV95ISsYCNkycDZN2v-9u6n-veo52AfXwPIuvgaqr97W-AGSxkpduCH0BYkPHkg |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA5DQb34W5xOzcGDBzu6Nklb8DJ0c2q3g2ywg1KSJYHp1onbQPzrfUnbOT2Jl9KSpITXvOb7Xl6-IHQuIkLpoEYdJULiEK2oIyLJHcEp40zpwFWGKLY7rNUj933aL6GrYi9Mpg-xCLgZz7D_a-PgJiC95OV8NKqaKApwn1Vwd2oJ1eO3eFSQR1gAQTgE_DrXFTJ5PIumP3DlMjq100tzCz0XHcuySl6r85moDj5_aTb-t-fbaDPHnbieDZQdVFLpLlpr5yvre-jpRulhavO3LjEfjqdwTSUejov8clOCJxrf1r240cE98yLg2Ryb-DBgSFO2UK21bRsfdlUAHvdRr9noXrec_OQF58WI5zgyUDDNezXpSp9FkYwi7XOARr7W5qwryXRNEaEjV3IG85vHgbQEIQOuRYHwEuIfoJV0kqpDhKFqQKkYAC2khMuQB8T1fT1wPR4q5qoyqhRfIMndZ5pYWTojM0PL6MKaMnnLxDeSgrSADRNrw6Qex_bm6O9Vz9B6q9uOk_iu83CMNgAEsSypr4JWZu9zdQJAYyZO7Xj6AgUhy7Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA5jwvDib3E6NQcPHuzo2iRt8TTc5q9uiDjYYVDSJoHp1g23gfjX-5K2c3oSL6UlSQmvec33vbx8QegiDgilSYNaMvaJRZSkVhwIbsWcMs6k8mypiWK3x-765GFAByV0XeyFyfQhVgE37Rnmf60dfCbUmpPz8biugyhAfTYIcx09pFvP39pRXh5gAQBhEXDrXFZIp_Gsmv6Alevg1MwunW00LPqVJZW81ZeLuJ58_pJs_GfHd9BWjjpxMxsmu6gk0z1U6ebr6vto2JJqlJrsrSvMR5M5XFOBR5Miu1yX4KnCt00nbPdwX78IWDbHOjoMCFKXrTRrTdv2h1kTgMcD1O-0X27urPzcBetVS-dYwpMwyTsNYQuXBYEIAuVyAEauUvqkK8FUQ5JYBbbgDGY3hwNl8XwGTIsC3SXEPUTldJrKI4ShqkdpnAAppIQLn3vEdl2V2A73JbNlFdWKDxDlzjOPjCidFpmhVXRpLBnNMumNqKAsYMPI2DBqhqG5Of571XNUeWp1ovC-93iCNgEBsSyjr4bKi_elPAWUsYjPzGj6AstIymM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Definition%2C+aims%2C+and+implementation+of+GA2LEN+Urticaria+Centers+of+Reference+and+Excellence&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Maurer%2C+M.&rft.au=Metz%2C+M.&rft.au=Bindslev%E2%80%90Jensen%2C+C.&rft.au=Bousquet%2C+J.&rft.date=2016-08-01&rft.issn=0105-4538&rft.eissn=1398-9995&rft.volume=71&rft.issue=8&rft.spage=1210&rft.epage=1218&rft_id=info:doi/10.1111%2Fall.12901&rft.externalDBID=10.1111%252Fall.12901&rft.externalDocID=ALL12901 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon |